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Abstract: 
 
Numerous factors have, to date, been identified as playing a role in the regulation of Agr activity 
in Staphylococcus aureus, including transcription factors, antisense RNAs, and host elements. 
Herein we investigated the product of SAUSA300_1984 (termed MroQ), a transmembrane Abi-
domain/M79 protease-family protein, as a novel effector of this system. Using a USA300 mroQ 
mutant, we observed a drastic reduction in proteolysis, hemolysis, and pigmentation that was 
fully complementable. This appears to result from diminished agr activity, as transcriptional 
analysis revealed significant decreases in expression of both RNAII and RNAIII in the mroQ 
mutant. Such effects appear to be direct, rather than indirect, as known agr effectors 
demonstrated limited alterations in their activity upon mroQ disruption. A comparison of RNA 
sequencing data sets for both mroQ and agr mutants revealed a profound overlap in their 
regulomes, with the majority of factors affected being known virulence determinants. 
Importantly, the preponderance of alterations in expression were more striking in the agr mutant, 
indicating that MroQ is necessary, but not sufficient, for Agr function. Mechanism profiling 
revealed that putative residues for metalloprotease activity within MroQ are required for its Agr-
controlling effect; however, this was not wielded at the level of AgrD processing. Virulence 
assessment demonstrated that both mroQ and agr mutants exhibited increased formation of renal 
abscesses but decreased skin abscess formation alongside diminished dermonecrosis. 
Collectively, we present the characterization of a novel agr effector in S. aureus which would 
appear to be a direct regulator, potentially functioning via interaction with the AgrC histidine 
kinase. 
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Article: 
INTRODUCTION 
Pathogenicity in Staphylococcus aureus is both diverse and tightly controlled, being highly 
adaptive to the surrounding environment and available resources (1). In order to survive and 
persist within the host, this pathogen produces a wide array of virulence factors throughout the 
different stages of infection (2). For example, during earlier phases of growth, adhesins and other 
binding proteins are actively synthesized (e.g., Spa, FnbAB) and play a role in colonization 
(2, 3). In contrast, in later phases, these surface proteins are repressed, while secreted toxins, 
proteases, and exoenzymes are produced to facilitate invasion and dissemination (2, 4). This 
coordination is facilitated by an array of global regulators of gene expression (2, 5–10). 
 
The agr quorum-sensing system is one of the most important regulators of virulence in S. 
aureus (11). It is a quorum-sensing system comprised of two transcriptional units, RNAII and 
RNAIII, each controlled by its own promoter, P2 and P3, respectively. RNAII encodes the agr 
operon, which is comprised of four genes, agrBDCA (12). The quorum-sensing system functions 
in three parts: (i) a quorum-sensing module comprised of AgrB and AgrD, (ii) a two-component 
system (TCS) consisting of AgrC and AgrA, and (iii) an effector molecule, termed RNAIII, 
which serves as a regulatory RNA (2, 12, 13). The pheromone for the agr system is known as 
autoinducing peptide (AIP) and is a derivative of the AgrD polypeptide. In order to reach its 
active form (AIP), AgrD is initially processed by AgrB, a multifunctional endopeptidase that 
also acts as a chaperone, followed by processing by the SpsB signal peptidase (14, 15). AIP is 
exported by AgrB and accumulates extracellularly until a threshold is reached, when it binds 
AgrC, the histidine kinase (HK) of the TCS. This leads to autophosphorylation of the protein 
(12, 16), followed by transfer of that phosphate to AgrA, the cytoplasmic response regulator 
(RR) (15). Upon activation, AgrA directly binds to the P2 and P3 promoters, upregulating 
expression of RNAII, as a positive feedback loop, as well as RNAIII (12). RNAIII subsequently 
modulates the expression of an assortment of genes involved in virulence, thus exerting the 
crucial role of agr in S. aureus pathogenesis. To date, numerous regulators of agr have been 
identified (5, 7, 8, 17–21), including transcription factors, such as SarR and CodY (5, 20); 
antisense RNAs, such as the psm-mec RNA transcript (22); and host factors, such as the serum 
protein apolipoprotein B (23). 
 
Abi proteins have previously been noted to play a protective role against viral infection by 
halting cellular activity in infected bacterial cells, so as to prevent further replication of the 
invading bacteriophage (24). These proteins are also members of the M79 metalloprotease 
family, which in eukaryotes are also noted as CAAX prenyl proteases (25, 26). These eukaryotic 
proteases are involved in posttranslational modification through a mechanism known as 
prenylation, where the AAX motif of target proteins is cleaved from the C terminus by M79 
enzymes, followed by the addition of an isoprenoid on the remaining cysteine residue (27). Work 
by our group exploring the prenylation process in bacteria has demonstrated that the C-terminal 
CAAX motif is present in only a few proteins, suggesting that this mechanism is not conserved 
in prokaryotes (28). Indeed, only a single protein has been shown to be prenylated in bacteria: 
ComX from Bacillales species is known to be prenylated at a conserved C-terminal tryptophan 
residue (29), although it is not known if proteolysis is a requirement for this event. 
 
Beyond a role in protecting against phage infection, Abi proteins have been characterized in only 
two other studies. The first, Abx1, has been the subject of study in group B streptococci (27). 
Notably, an abx1 mutant demonstrated a significant decrease in hemolytic activity and pigment 
production, which was mediated via increased CovSR activity (27). In this work, Abx1 was 
shown to positively regulate CovS, a histidine kinase involved in virulence gene regulation, by 
forming a signaling complex. Moreover, the interaction was established to be direct, via the two 
CovS transmembrane domains, but not dependent on Abx1 proteolytic activity (27). More 
recently, an Abi-domain protein in S. aureus, SpdC, was characterized and shown to interact 
with the histidine kinase of the WalKR two-component system, which is involved in controlling 
cell wall metabolism (30). SpdC was also shown to interact with other histidine kinases, 
including SaeS, ArlS, and VraS, through interaction between transmembrane domains (30). Of 
note, although it is an Abi protein, SpdC lacks the conserved catalytic residues of M79 enzymes, 
and therefore it is a nonpeptidase homolog. As such, although they are still relatively 
underexplored, it is becoming increasingly apparent that Abi proteins in prokaryotes possess 
important regulatory functions that are seemingly mediated through interaction with the histidine 
kinase modules of two-component systems (27, 30). 
 
In S. aureus, beyond SpdC, there are 5 other Abi-domain proteins encoded within the genome. 
Herein, we investigate the function of one of these, SAUSA300_1984, which is encoded by a 
region located upstream of the agr operon and which we name MroQ. We show that mutation 
of mroQ results in the decreased expression and abundance of secreted proteases, hemolysins, 
and toxins, as well as the increased production of surface-associated proteins. These effects were 
shown to be agr dependent, with the mroQ mutant demonstrating decreased expression of both 
RNAII and RNAIII. Importantly, known regulators of agr demonstrated limited alterations in 
transcription, potentially indicating a direct role for MroQ in controlling agr activity. We also 
noted decreased pigment production and enhanced biofilm formation in the mroQ mutant, which 
mirrored that of an agr mutant. Finally, we observed a decreased bacterial burden and 
dermonecrosis for mroQ mutant-infected mice using a model of skin abscess formation. 
Collectively, we present the characterization of a novel agr effector in S. aureus, which would 
appear to be a direct regulator, potentially functioning via interaction with the AgrC HK 
component. 
RESULTS 
MroQ serves to control protease production in S. aureus. Given the Shaw laboratory's long-
standing interest in S. aureus secreted proteases, we screened the Nebraska Transposon Mutant 
Library (NTML) (31) for novel factors that could regulate their production. Using this mutant 
collection and casein agar plates, we identified an insertion in the gene SAUSA300_1984 
(hereafter named mroQ, for membrane protease regulator of Agr quorum sensing) that elicited a 
profound reduction in secreted protease activity (Fig. 1A). To explore this more broadly, we next 
analyzed proteolytic activity through gelatin zymography (Fig. 1B). Here, the mroQ mutant 
demonstrated a substantial decrease in the levels of multiple secreted proteases, which was 
rescued upon complementation in trans; indeed, complementation with a multicopy plasmid 
actually led to an increase in the production of secreted proteases in comparison to that in our 
wild-type strain. Next, to determine if the influence of MroQ on protease production was a 
consequence of modulated activity or altered transcription, we used a reporter gene fusion for the 
protease aureolysin. When this fusion was transduced into the USA300 wild type and mroQ 
mutant, we observed a significant impairment in aureolysin transcription in the mutant strain 
(Fig. 1C), thus indicating that the effects are wielded at the level of gene expression. 
 
 
FIGURE 1. Disruption of mroQ results in diminished proteolytic activity in S. aureus. (A) The 
wild type (WT), mroQ mutant (mroQ−), mroQ-complemented strain (mroQ+), mroQ site-directed 
mutant (E141A/E142A)-complemented strain (mroQ− E141A/E142A), and agr mutant strain 
(agr−) were plated on casein nutrient agar to observe changes in proteolysis. Red arrows 
highlight zones of proteolysis. (B) Gelatin zymography of the indicated strains. Note that white 
zones of clearing indicate proteolysis of the gelatin substrate. (C) Activity of an aur-lacZ fusion 
in the wild-type, mroQ mutant, and agr mutant strains. Data are from 4 h of growth, which is a 
peak window of aureolysin expression. Student's t test was used to determine statistical 
significance. *, P < 0.05; **, P < 0.01. Error bars show the SEM. EV, empty vector. 
 
MroQ regulates the production of a wealth of S. aureus virulence determinants. To 
determine if the observed effects were specific to proteases, we next explored whether the 
production of other virulence factors was influenced by MroQ. Using a blood agar plate, we 
observed a significant decrease in hemolytic activity for the mutant strain compared to that for 
the wild type (Fig. 2A) that was restored upon complementation in trans. This activity was 
explored quantitatively using a hemolysin assay with whole human blood, revealing a substantial 
decrease in the ability of the mutant to lyse human erythrocytes, which was again 
complementable (Fig. 2B). To assess whether this effect was mediated at the transcriptional 
level, we used a reporter gene fusion for the primary hemolysin in S. aureus, hla. When the 
activity of this construct was assessed between the wild type and the mroQ-null strain, we 
observed a significant decrease in the mutant, indicating that these effects are also mediated at 
the level of gene expression (Fig. 2C). To further investigate the role of MroQ and its influence 
on other virulence determinants, we performed a Western blot analysis for the Panton-Valentine 
leukocidin (PVL) toxin and the surface-exposed virulence factor surface protein A (Spa). Upon 
analysis we determined that PVL was highly abundant in the wild type and the mroQ-
complemented strain; however, it was entirely absent in the mroQ mutant (Fig. 2D). Conversely, 
in blots with Spa, we found an increased abundance in the mroQ mutant, whereas we noted an 
absence in the wild type and the mroQ-complemented strain (Fig. 2E). To ensure that these 
substantial changes in virulence factor production were not the result of a simple growth defect 
in the mutant, we measured cell density over time. We found no significant difference when 
performing these studies between the wild-type, mutant and complemented strains (data not 
shown). 
 
 
FIGURE 2. MroQ globally regulates virulence factor production in S. aureus. (A) The wild 
type, mroQ mutant, mroQ-complemented strain, mroQ site-directed mutant (E141A/E142A)-
complemented strain and agr mutant strain were plated on sheep blood agar to observe changes 
in hemolysis. (B) Hemolytic activity was measured via lysis of erythrocytes in whole human 
blood. (C) Activity of an hla-lacZ fusion in the wild-type, mroQ mutant, and agr mutant strains. 
Data are from 4 h of growth, which is a peak window of alpha-hemolysin expression. (D, E) 
Immunoblots for abundance of the LukS component of the Panton-Valentine leukocidin (PVL) 
(D) and surface protein A (SpA) (E) in the wild-type, mroQ mutant, and complemented strains. 
Student's t test was used to determine statistical significance. **, P < 0.01; ***, P < 0.001; ns, not 
significant. Error bars show the SEM. EV, empty vector. 
 
MroQ mediates its effects via modulation of agr activity in S. aureus. Our findings thus far 
for the mroQ mutant are in line with those which one might expect for a strain exhibiting altered 
activity of the central virulence factor regulator, agr. Indeed, when we repeated our proteolysis 
and hemolysis activity and transcription studies whose results are presented in Fig. 1 and 2 with 
an agr mutant strain, we saw results very similar to those obtained with the mroQ mutant. As 
such, we next sought to assess changes in promoter activity for the agr P2 and P3 promoters in 
the mroQ mutant using quantitative real-time PCR (qPCR) analysis (Fig. 3). When the 
abundance of the RNAII (Fig. 3A) and RNAIII (Fig. 3B) gene transcripts was measured, we 
observed a marked decrease for both transcripts in the mutant compared to the parent. 
Specifically, the activity from the P2 promoter was decreased by 15.6-fold, while the activity 
from the P3 promoter was decreased a striking 292-fold. 
 
 
FIGURE 3. The RNAII and RNAIII genes are significantly downregulated upon mroQ 
disruption. qPCR was performed on the mroQ mutant and USA300 wild-type strains grown in 
TSB to late exponential phase. Target expression levels were normalized to the 16S rRNA 
expression level. agrB was used as a measure of RNAII gene transcript abundance (A), and 
RNAIII was examined for transcript abundance (B). Student's t test was used to determine 
statistical significance. ****, P ≤ 0.0001. Error bars show the SEM. 
 
To further clarify these effects, we next assessed the transcription of a range of genes 
downstream of agr whose transcription is dependent on its activity. Here, some very notable 
changes in expression between the wild type and the mutant were observed, including the 
expression of numerous genes involved in virulence that are positively regulated by agr. 
Specifically, decreases in the mutant strain were observed for psmα1 (2,666-fold), sspA (57.3-
fold), lukS-PV (35.4-fold), and lip (132.2-fold). Further, the notable regulator saeR, which is 
positively influenced by the agr system, demonstrated a 3.8-fold decrease in transcription in the 
mutant. Additionally, spa, which is repressed by the agr effector RNAIII, demonstrated a 792-
fold increase in transcription in the mutant, as did the notable SarA homolog sarS (which is also 
negatively regulated by agr), which was found to have a 2.1-fold increase in transcription. 
Another surface protein that is repressed by RNAIII, sdrD, also demonstrated a 2.7-fold increase 
in transcription in the mutant strain (Fig. 4). 
 
To determine if these were likely direct or indirect effects, we next sought to measure the 
expression of a cadre of known upstream effectors of the agr system. Accordingly, expression of 
positive (sarA, sarZ, sarU, and mgrA) and negative (arlR, sarR, sarX, rsr, codY, and sigB) 
regulators of agr activity was studied by qPCR in the mroQ mutant and the parental strain (Fig. 
5; see also Table S1 in the supplemental material). Importantly, when these experiments were 
performed, we observed no significant alteration in the transcription of key agr repressors, such 
as sigB (1.1-fold decrease), sarX (1.1-fold decrease), rsr (1.2-fold decrease), and codY (1.2-fold 
increase). Moreover, although changes of merit were observed for two other agr repressors, arlR 
(1.8-fold decrease) and sarR (8.2-fold decrease), these were both negative effects and, thus, do 
not explain the phenotypes observed. When looking at positive regulators of agr, we did observe 
decreased expression for a number of factors, but none at levels that would prove causative to the 
large decreases in agr activity (292-fold decrease in P3 activity in the mroQ mutant) thus far 
observed: sarA (3.1-fold decrease), sarZ (2-fold decrease), sarU (2.1-fold decrease), and mgrA 
(1.9-fold decrease). As such, although the findings are not definitive, it would appear that the 
positive impact of MroQ on agr activity is mediated either by direct interaction or via an as yet 
unknown regulator of this system. 
 
 
FIGURE 4. The expression of genes regulated by Agr is altered in the mroQ mutant. qPCR was 
performed on the mroQ mutant and USA300 wild-type strains grown in TSB to late exponential 
phase. Expression levels were normalized to the level of 16S rRNA expression. Student's t test 
was used to determine statistical significance. **, P < 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001. 
Error bars show the SEM. 
 
 
FIGURE 5. Alterations in expression of known regulators of agr in the mroQ mutant. qPCR was 
performed on the mroQ mutant and USA300 wild-type strains grown in TSB to late exponential 
phase. Target expression levels were normalized to the level of 16S rRNA expression. 
Student's t test was used to determine statistical significance. **, P ≤ 0.01; ***, P ≤ 0.001; ns, not 
significant. Error bars show the SEM. 
 
Probing the role of MroQ using a global transcriptomic approach. To gain a more global 
insight into the regulatory effects of MroQ in S. aureus, we examined the transcriptome using 
RNA sequencing (RNA-seq) analysis on our USA300 mroQ mutant and its parental strain. A 
genomic map was created to demonstrate the changes in the transcriptome between the mroQ 
mutant and the parent, as well as the fold changes in gene expression, denoted by a heat map 
(Fig. 6A). Upon analysis, we found that expression of 123 genes/small RNAs (sRNAs) was 
decreased in the mroQ mutant, and 109 were increased at a level of ≥3-fold (Fig. 6B; Table S2). 
Importantly, these studies confirmed our previous data, demonstrating that all components of the 
Agr system were indeed downregulated in the mroQ mutant, with the largest decreases being 
observed in its two-component system, AgrC (21.6-fold) and AgrA (22.2-fold). When changes 
were clustered ontologically, the most downregulated group was genes for virulence factors, with 
28 genes being decreased in expression in the mutant (Fig. 6C). Furthermore, our previous data 
regarding virulence factor expression were supported, with significant changes being observed 
for proteases, toxins, and surface-associated proteins. For example, decreased expression was 
observed for the phenol-soluble modulins (PSMs) (695-fold), lukS-PV (63.5-fold), sspA (47-
fold), and scpA (10-fold) in the mutant strain When looking at the microbial surface component 
recognizing adhesive matrix molecules (MSCRAMMs), sdrD and spa demonstrated 5.2-fold and 
58.1-fold increases in transcription, respectively, in our mroQ mutant. 
 
 
FIGURE 6. mroQ disruption produces a global alteration in S. aureus gene expression. RNA-
seq was performed on the USA300 wild type and its mroQ mutant strain. Cultures were grown in 
TSB to late exponential phase in biological triplicate. RNA was isolated, and the total RNA of 
replicates was processed for sequencing on an Ion Torrent PGM system. (A) A genomic map 
was created to denote changes in the mroQ mutant transcriptome (inner circle, purple) compared 
to the wild-type transcriptome (middle circle, black). The outermost circle is a heat map 
demonstrating fold changes in expression. (B, C) Depiction of the number of genes upregulated 
and downregulated (B), which were sorted into ontological groups based on known or predicted 
function (C). 
 
Considering the clear evidence indicating decreased Agr activity in the mroQ mutant and the fact 
that the most profound changes observed in transcription were for virulence determinants, we 
next examined a full agr operon knockout using RNA-seq analysis. A genomic map was created 
to demonstrate the changes in the transcriptome between the agr mutant and the wild type, as 
well as the fold changes in gene expression via a heat map (Fig. 7A). Implementation of a 3-fold 
cutoff demonstrated that the expression of 222 genes/sRNAs was decreased and that the 
expression of 262 was increased in the agr-null strain (Fig. 7B; Table S3). When reviewed 
ontologically, the cluster of genes that appeared to be the most downregulated was, again, genes 
for virulence factors (Fig. 7C). Upon comparing the mroQ mutant transcriptome to that of the 
agr mutant, we found a 55% similarity in altered genes and sRNAs (Fig. S1). Of these 129 
shared genes, a quarter of them encode virulence factors. It is important to note that the 
percentage of shared genes/sRNAs is likely higher between the two mutants, as numerous genes 
identified in the mroQ mutant data set are known to be regulated by Agr; however, due to 
parameters implemented during analysis, they were not present in the agr mutant data set 
because they were expressed at levels too low to be detected upon deletion of agr. Additionally, 
although there were numerous genes whose expression was changed only in the mroQ mutant 
transcriptome, >60% encode hypothetical proteins, thus hampering their functional exploration. 
To validate the findings for both transcriptome studies, we performed qPCR analysis on a 
random selection of genes (Table S4), with each showing changes that reproduce those seen in 
our RNA-seq data sets. 
 
 
FIGURE 7. Transcriptomic profiling of an agr operon deletion mutant. RNA-seq was performed 
on the USA300 wild type and its agr mutant strain. Cultures were grown in TSB to late 
exponential phase in biological triplicate. RNA was isolated, and the total RNA of replicates was 
processed for sequencing on an Ion Torrent PGM system. (A) A genomic map was created to 
denote changes in the agr transcriptome (inner circle, green) compared to the wild-type 
transcriptome (middle circle, black). The outermost circle is a heat map demonstrating fold 
changes in expression. (B, C) Depiction of the number of genes upregulated and downregulated 
(B), which were sorted into ontological groups based on known or predicted function (C). 
 
Collectively, the profound similarity in transcriptomes again suggests that mutation of mroQ 
elicits an agr mutant-like phenotype. It is important to note, however, that ablated MroQ activity 
elicits an intermediate agr-deficient phenotype, rather than a complete null effect. This is 
evidenced through a comparison of the fold changes in expression for primary virulence factors 
between the mroQ and agr mutants (Table 1), where mroQ disruption results in less profound 
changes in expression than agr deletion. 
 
Mutation of mroQ enhances biofilm formation. Given the noted increase in the abundance of 
surface proteins and the marked decrease in virulence factor activity in our mroQ mutant strain, 
we hypothesized that mroQ disruption would lead to enhanced biofilm formation, as seen 
with agr mutant strains (32). Using the classic crystal violet assay for biofilm formation, 
previously described by ourselves and others (33), we determined that the mroQ mutant strain 
did indeed produce a more robust biofilm than our USA300 wild-type strain, with the levels 
being similar to those for an agr mutant (Fig. 8). This effect was restored to wild-type biofilm 
formation levels following complementation with mroQ in trans. These results are consistent 
with those previously seen for agr mutants in multiple different S. aureus backgrounds (32, 34). 
 
TABLE 1. Comparison of genes/sRNAs demonstrating changes in expression in 
both mroQ and agr mutant RNA-seq data sets 
Gene/sRNA 
Fold change in expression 
mroQ mutant agr mutant 
RNAIII gene −338.2 −162,355.9 
splA −903.1 −1,409.3 
lukS-PV −63.5 −150.2 
sspA −47.5 −90.47 
splB −44.0 −129.1 
splE −43.8 −97.2 
lukF-PV −43.1 −104.8 
hlb (SAUSA300_1918) −25.2 −64.7 
cap5D −21.2 −56.0 
cap5B −11.1 −27.5 
lukB −9.8 −21.4 
lukA −9.4 −28.4 
ear −9.0 −82.4 
cap5F −4.6 −11.1 
scinA −3.3 −19.1 
saeR −3.1 −8.0 
sdrD +5.23 +10.2 
spa +58.1 +242.2 
SAUSA300s097 +79.5 +164.2 
 
Disruption of mroQ leads to an agr-mediated decrease in staphyloxanthin production and 
impaired tolerance to oxidative stress. During our work with the mroQ and agr mutant strains, 
we observed that both appeared to have a decrease in the characteristic golden pigment produced 
by S. aureus (Fig. 9A). Due to the importance of staphyloxanthin in protecting S. aureus against 
reactive oxygen species, we performed oxidative stress assays with our collection of strains (Fig. 
9B) alongside a sigB-null mutant as a pigment-lacking control. Accordingly, strains were 
exposed to hydrogen peroxide (H2O2) at a concentration of 20 mM for 30 min. Following this, 
the number of CFU per milliliter was determined and compared to that in the inoculum, 
producing the percent recovery for each strain. As expected, the sigB knockout strain 
demonstrated only 0.18% survival under these conditions, while the wild-type strain produced 
20.9% recovery. The mroQ mutant demonstrated 3.0% recovery in comparison to our parental 
strain, while the agr mutant demonstrated 2.5% recovery. Importantly, complementation of 
the mroQ mutant resulted in wild-type levels of survival under these conditions. These findings 
indicate that, in accordance with decreased staphyloxanthin production, the mroQ and agr 
mutants both demonstrated reduced tolerance to oxidative stress. 
 
 
FIGURE 8. The mroQ mutant demonstrates an increased capacity for biofilm formation. Strains 
were grown in 24-well plates in TSB medium containing 5% human plasma. Biofilm formation 
was quantified with crystal violet staining, followed by extraction with 100% ethanol and 
OD550 measurement. Assays were performed in biological triplicate and technical duplicate. 
Student's t test was used to determine statistical significance. *, P < 0.05; ***, P ≤ 0.001; ns, not 
significant. Error bars show the SEM. EV, empty vector. 
 
 
FIGURE 9. Staphyloxanthin production and tolerance to oxidative stress are decreased in 
the mroQ mutant in an agr-dependent manner. (A) The strains indicated were streaked onto TSA 
and grown overnight. (B) Percent recovery of strains following 30 min exposure to H2O2 at a 
20 mM concentration. Student's t test was used to determine statistical significance. **, P ≤ 0.01; 
ns, not significant. Error bars show the SEM. EV, empty vector. 
 
MroQ elicits protease-dependent control of Agr activity. As previously discussed, Abi-
domain proteins also belong to the M79 metalloprotease family (25, 27, 35). These enzymes are 
defined by several conserved motifs, with the primary one being a catalytic dyad comprised of 
neighboring glutamic acid residues (Fig. S2) (25). Thus far, the conserved protease residues of 
Abi-domain proteins have not been demonstrated as having essential roles in their function in 
previous studies involving Gram-positive bacteria (27, 30). As such, we sought to investigate the 
importance of proteolytic activity for MroQ in exerting its Agr-modulating effects. To do this we 
created a catalytically inert complementing strain, where the proteolytic residues were converted 
from glutamic acid to alanine (E141A/E142A) (Fig. S3A). Upon introducing this construct into 
the mroQ mutant strain, we found that this site-directed mutant complement did not restore 
proteolytic or hemolytic activity to S. aureus (Fig. 1A and 2A), demonstrating levels equivalent 
to those in the mroQ and agr mutant strains. As such, these results indicate that MroQ is the first 
Gram-positive bacterial Abi protein to be dependent on its proteolytic capacity for function. 
 
 
FIGURE 10. Despite impaired agr activity, the mroQ mutant still produces fully mature AIP. 
Culture supernatants from the wild type, the mroQ mutant, the agr mutant, and the mroQ-
complemented strain, alongside sterile TSB with or without purified AIP-I, underwent UPLC-
MS/MS analysis. Experiments were performed three times for each condition, with the 
chromatograms and spectra shown here proving representative. (A) Chromatograms showing the 
elution of peptides matching the AIP standard are presented. Peaks at a retention time (RT) of 
2.20 to 2.23 min highlighted in yellow correspond to mature AIP-I, and for all conditions, peaks 
with ∼100% relative abundance are labeled with the RT and the peak area (AA). (B) MS/MS 
spectra comparing the relative abundance of the MRM transitions (m/z 961.3 to 711.2 and 365.9) 
at a retention time of ∼2.20 min for the 0.1-ng/ml AIP-I standard, wild type (WT), 
and mroQ mutant shown below a schematic of AIP-I, with the transitions indicated by dotted red 
lines. The first enables liberation of the y6 ion of AIP (calculated m/z 711.30), while the second 
fragments the cyclic part of AIP, bMI, a prevalent fragment of the cyclic component of AIP 
(calculated m/z 366.23). EV, empty vector. 
 
The presence of mature AIP in mroQ mutant supernatants indicates that it plays no role in 
the processing of AgrD. Given that MroQ controls agr activity in a protease-dependent manner 
and that a central component of the Agr system (the AgrD pheromone precursor) is subject to 
proteolytic processing, we set out to explore whether MroQ is required for AIP maturation. As 
such, we used ultraperformance liquid chromatography (UPLC)-tandem mass spectrometry 
(MS/MS) analysis to identify mature AIP in the culture supernatants of our various strains. In so 
doing, we observed AIP-I (retention time [RT] = 2.20 to 2.23 min) in culture supernatants for the 
wild type, mroQ mutant, and mroQ-complemented strains but not in the agr mutant or in the 
tryptic soy broth (TSB) blank control (Fig. 10A). Importantly, when analyzing fragmentation 
patterns, the expected fragments of AIP-I (36) were also observed in supernatants of the wild 
type and mroQ mutant (Fig. 10B) but not in those of the agr-null strain. Next, the area under the 
curve (AA) of AIP peaks in Fig. 10A, in conjunction with an AIP-I standard curve, was used to 
calculate the AIP-I concentrations in the various culture supernatants (36) (Table S5). Although 
the level of the mroQ mutant was below the lower threshold for accurate quantification 
(0.1 ng/ml), extrapolation analysis suggested that the level of secretion of mature AIP-I was ∼50-
fold lower in the mutant than in the wild type (AA = 260,301 and 3,224 for the wild type and 
the mroQ mutant, respectively). 
 
As such, it appears that MroQ does not exert its protease-dependent effects on agr activity via 
direct processing of AgrD or by preventing the proteolytic activity of AgrB (or SpsB, which is 
also required for AgrD cleavage [37, 38]). 
 
 
FIGURE 11. Mutation of mroQ results in increased renal abscess formation. Female 6-week-old 
CD-1 mice were injected with the strains shown, and infections were allowed to proceed for 
7 days. Following the infection period, mice were sacrificed and the kidneys were harvested. (A) 
Organs were homogenized in 1 ml of PBS, serially diluted, and plated on TSA to determine the 
bacterial burden. A Mann-Whitney test was used to determine statistical significance. ns, not 
significant. (B) Representative images of kidneys harvested from mice infected with the strains 
noted. 
 
MroQ plays an important role during abscess formation in both localized and systemic 
infections. Using murine models of infection, we compared the virulent capacity of 
the mroQ and agr mutants alongside that of our wild-type strain in systemic and localized 
infections. Upon assessing the mortality of mice infected with each strain during a murine model 
of sepsis and dissemination, we observed no overall difference in survival across the three strains 
(data not shown). This is perhaps not surprising, given that the agr system has previously been 
shown to have a limited role in influencing this kind of infectious capacity (4, 39). Interestingly, 
however, we noted that although the kidneys of mice infected with both mutant strains had no 
alteration in bacterial burden (Fig. 11A), they had an increase in abscess formation (Fig. 11B). 
Although this finding is curious, it has previously been shown that a defective Agr system results 
in the increased production of surface factors that are important to abscess formation while, at 
the same time, limits the production of secreted factors required for dissemination from the 
abscess (40). As such, this would explain why the mroQ mutant demonstrates an increase in 
renal abscess formation compared to that of the wild type, which mirrors, albeit to a lesser 
extent, that of a complete agr deletion strain. 
 
 
FIGURE 12. The mroQ mutant demonstrates attenuated virulence in a murine abscess model of 
skin infection. Female 6-week-old BALB/c mice were injected subcutaneously, and infections 
were allowed to proceed for 7 days. (A) Abscesses were measured (width and height), and the 
area was calculated. (B) The bacterial burden was determined for each abscess. Student's t test 
was used to determine statistical significance. *, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; 
****, P ≤ 0.0001. Error bars show the SEM. 
 
Skin and soft tissue infections (SSTIs) are commonly caused by S. aureus, particularly by 
USA300 isolates, which are the predominant cause of SSTIs in the United States (41). The 
success of community-acquired methicillin-resistant S. aureus (CA-MRSA) strains in causing 
SSTIs is a result of their overproduction of important virulence factors (Hla, PSMs, secreted 
proteases) arising from a hyperactive Agr system (42). To investigate the requirement for MroQ 
in this kind of localized infection, we next used a murine model of subcutaneous abscess 
formation with our collection of strains. Following the 7-day infection period, mice were 
sacrificed, abscesses were excised and measured, and the bacterial burden was determined for 
each abscess. Upon measuring the abscess area (in square millimeters), the mroQ mutant had a 
2-fold decrease in comparison to that for the wild type, while the agr mutant had a 4.5-fold 
decrease (Fig. 12A). Additionally, the mroQ mutant demonstrated decreased bacterial recovery 
in the abscess model (5.2-fold decrease) compared to the parent, and although this decrease was 
significant, it was not at the same magnitude as that in the agr mutant (212.2-fold decrease) (Fig. 
12B). Finally, the mroQ mutant presented decreased levels of dermonecrosis compared to the 
parental strain, while the agr mutant produced no detectable areas of dermonecrosis at all (Fig. 
S4). This finding is perhaps to be expected, given that this kind of pathology has previously been 
shown to heavily depend on Agr-regulated factors (41, 43). Collectively, mroQ disruption results 
in attenuated virulence and dermonecrosis in models of localized skin infection that likely arise 
from impaired, although not ablated, Agr activity within this strain. 
DISCUSSION 
Numerous factors have, to date, been identified as playing a role in the regulation of Agr activity, 
including transcription factors, antisense RNAs, and host factors (5, 8, 20, 22, 23, 44). In this 
study, we characterized a novel Abi-domain protein and its previously unidentified role as a 
novel regulator of Agr. While exploring the impact of MroQ on agr function, we examined the 
expression of numerous known regulators of the agr system (Fig. 13), including activators and 
repressors (5, 20, 45). In sum, only one substantial alteration was observed among the collected 
repressors, which was for sarR transcription, although this change was, in fact, a decrease rather 
than upregulation. Regarding activators, some Sar-family member proteins, including MgrA and 
SarA, did demonstrate decreased expression; however, these effects were only ∼2- to 3-fold in 
magnitude. As such, the lack of significant changes observed in key repressors and activators 
does not appear to explain the substantial decreases observed in Agr activity upon mroQ 
disruption. These findings suggest that the influence of MroQ on Agr activity likely occurs 
through direct interaction with Agr proteins or through as yet unknown effectors of the system. 
 
 
FIGURE 13. Regulatory map illustrating known direct regulators of Agr activity. A map of agr 
regulators was developed based on the literature. Changes in expression of these regulators do 
not correlate with the substantial decrease in Agr activity observed upon mroQ disruption. MroQ 
appears to directly interact with Agr, resulting in a downstream effect on virulence factor 
production. Black arrows indicate activation, the red crossbar indicates repression, and the black 
dashed arrow indicates putative activation. 
 
How such a direct effect could be mediated is perhaps suggested by existing literature on other 
bacterial Abi proteins. In the first of two recent accounts characterizing Abi-domain proteins in 
Gram-positive bacteria, a protein called Abx1 was found to have a role in virulence gene 
expression in Streptococcus agalactiae (27). Using a two-hybrid study, it was revealed that Abx1 
interacts with the CovS histidine kinase, seemingly via the transmembrane domains of this 
protein (27). Of note, this interaction was not dependent on the proteolytic activity of Abx1, as 
mutation of its conserved Glu-Glu residues did not affect its function toward the CovRS system. 
This study represented a first of its kind, elucidating a novel function for Abi-domain proteins in 
Gram-positive bacteria. More recently, another Abi-domain protein was characterized in S. 
aureus (30). Here, Poupel et al. investigated SpdC, a membrane protein involved in an 
interaction network controlling the coordination of division with cell envelope metabolism and 
host interactions (30). In this study, it was determined that SpdC interacts with 10 different 
histidine kinases, with several interactions being through their transmembrane domains, similar 
to the findings in group B streptococci (27). Importantly, SpdC is one of the three Abi proteins 
in S. aureus (see Fig. S1 in the supplemental material) to lack the conserved EE catalytic 
residues, once again showing that proteolytic activity is not essential for its HK-regulating role. 
 
Thus far, our findings suggest that MroQ may interact directly with the Agr system to modulate 
its activity. The mroQ gene is encoded by a region ∼4 kb upstream of the agr operon and is 
expected (as with other Abi proteins) to specify a membrane protein. Importantly, when we 
performed localization studies for MroQ, we did indeed find that it is present only in membrane 
fractions (Fig. S3B). At this time, we have yet to confirm potential partners of the interaction for 
MroQ; however, considering the growing evidence demonstrating that Abi-domain proteins in 
Gram-positive pathogens interact with and regulate histidine kinases (27, 30), we suggest that 
MroQ could perhaps mediate its function through AgrC. We note that the Agr system also 
encodes another membrane protein, AgrB, and that this protein itself also functions as a protease 
(processing the AgrD pheromone precursor). Our data at this time do not, however, implicate 
AgrB as the target of MroQ. Specifically, our analysis of culture supernatants by mass 
spectrometry detected the presence of mature AIP produced by the mroQ mutant. As such, this 
would suggest that MroQ has no role in directly processing AgrD and is not required for AgrB to 
function correctly. Similarly, we believe that it is unlikely that MroQ is involved in processing 
AgrA, as AgrC-AgrA interactions have been extensively studied through various crystallization, 
biochemical, and biophysical studies and do not appear to need adapter proteins to engage (46). 
 
How MroQ might interact with its target(s) within the S. aureus cell is currently unclear, but it is 
seemingly dependent on its proteolytic activity. Members of the M79 peptidase family in 
eukaryotes typically cleave C-terminal tripeptides from isoprenylated proteins (47), with known 
substrates including Ras and Ras-related GTP-binding proteins and protein kinases (48). The 
latter category again provides a link between Abi/M79 proteins and kinase enzymes, further 
suggesting that AgrC may indeed be the target of MroQ. Determining if the C terminus of AgrC 
is subject to proteolysis for correct function is an important consideration for continued 
exploration of MroQ and its role within the S. aureus cell. 
 
Using RNA-seq analysis, we found that the entire agr system was downregulated in our mroQ 
mutant, with the most substantial decreases being observed for agrC and agrA, encoding the 
two-component system. When comparing this data set to a similar transcriptome generated with 
an agr operon deletion mutant, we observed 55% similarity in the transcriptomes between the 
two strains, with 25% of these changes corresponding to virulence factors. Of note, a large 
number of these virulence factors, although they were substantially altered in the mroQ mutant, 
were changed to a much greater degree in the agr mutant (Table 1). This is seen on a greater 
scale when observing trends in virulence factor production, where proteolytic and hemolytic 
activity was decreased but not completely diminished in the mroQ-null strain, as well as in 
virulence with our murine model of skin infection. Given that mroQ mutation phenocopies, but 
does not completely replicate, the act of agr deletion, we suggest that this protein is necessary, 
but not sufficient, for Agr activity in S. aureus. 
 
A singular concern presents itself in the context of our suggestion that mutation of mroQ creates 
a diminished but not abrogated agr phenotype: that our phenotype might arise from the fact that 
we used a mutational insertion strain rather than a deletion mutant. We are supported by the 
observation that, although there have been screens performed to uncover S. aureus mutants that 
result in ahemolytic phenotypes (49), MroQ has not been identified to date. However, to explore 
this more fully, we reviewed our mroQ mutant RNA sequencing data set and determined that 
transposon insertion successfully terminates the mroQ transcript at the point of insertion (Fig. 
S5). 
 
In the context of our virulence studies, we made a striking observation when considering the 
gross pathology presented in the kidneys of mice using a sepsis model. Here, abscess frequency 
and severity were increased in the mroQ mutant and were increased to an even greater level in 
the agr-null strain. At first this might seem contradictory; however, when one explores the 
literature regarding S. aureus abscess formation, this becomes more logical. Specifically, it is 
known that the early phases of abscess formation are largely dependent on Agr-repressed surface 
factors, such as Spa, SdrD, ClfA, and Coa. Furthermore, the later stages of infection are 
characterized by the rupturing of the abscess to elicit dissemination, a process known to be 
dependent on Agr-activated factors, such as secreted toxins and proteases (2, 50, 51). 
Accordingly, a defect in quorum sensing, as observed in the mroQ mutant, locks abscess 
formation in the early stages, preventing development to later phases, which are characterized by 
necrosis and dissemination to new sites (43). The finding that this is more severe in the agr 
mutant than in the mroQ-null strain is again in line with our notion that MroQ is a factor that 
contributes to Agr activity but is not the only factor doing so. 
 
As previously mentioned, models for skin infection are often used to represent SSTIs, which are 
commonly caused by USA300 strains (52). A key hallmark of subcutaneous skin infections by 
such strains is dermonecrosis, which presents as necrosis of the epidermis and dermis and which 
has previously been shown to heavily depend on the Agr-regulated factors alpha-hemolysin (Hla) 
and phenol-soluble modulins (PSMs) (41, 43, 53). Importantly, our mroQ mutant demonstrated 
decreased promoter activity for hla (3.7-fold decrease), although not to the level of an agr 
mutant (6.4-fold decrease). These transcription-based findings directly translate into virulence-
based outcomes, as the dermonecrosis presented by the mroQ mutant, although reduced 
compared to that presented by the wild type, was not absent, as was seen for the agr mutant. 
Similarly reduced-but-not-ablated findings for the mroQ mutant were presented from our study 
of abscess size and bacterial load per abscess, where, again, the agr mutant was profoundly 
impaired in its pathogenic potential compared to the parent. 
 
Agr-related factors also play a role in biofilm formation largely identical to that which they play 
in abscess formation, which explains why agr-defective strains demonstrate increased formation 
of biofilms (51). Biofilms undergo a cycle comprised of three stages: initial attachment, 
maturation, and dispersal (51, 54). During the initial attachment, adhesin proteins play a crucial 
role in attachment to an abiotic or biotic surface, as well as in the maturation phase, where they 
are important for cell-cell adhesion. Conversely, the dispersal of biofilms is highly dependent on 
enzymes, such as proteases and nucleases, produced by the bacteria to break down components 
of the biofilm matrix, ultimately allowing for the continuation of the biofilm life cycle from 
planktonic cells (51). Our mroQ mutant demonstrated excellent initial attachment and 
maturation, likely due to its increased production of MSCRAMMs; however, it failed to properly 
disperse due to decreased Agr activity and, therefore, decreased the production of secreted 
enzymes necessary for breaking down the extracellular matrix (51). 
 
In summary, this study identifies MroQ, a novel transmembrane protein, as having a critical role 
in the regulation of virulence factor production via modulation of the agr quorum-sensing 
system. Further studies are required in order to elucidate the mechanism by which modulation 
occurs and, more specifically, to identify the MroQ partner(s) of the interaction. Moreover, we 
must determine how proteolysis is necessary to the function of MroQ, especially considering that 
this is the first characterized Abi-domain protein to demonstrate protease-dependent activity. In 
addition, four other Abi-domain proteins exist in S. aureus, SAUSA300_0932, 
SAUSA300_2405, SpdA, and SpdB, the last two of which have been shown to have a role in 
surface protein regulation (35). Given that surface protein display is under the control of several 
TCSs in S. aureus (55–57), it is entirely possible that they may function by interaction with HKs 
as well. Accordingly, the continued characterization of MroQ and the complete set of Abi-
domain proteins in S. aureus remains a focus of study in the Shaw laboratory. 
MATERIALS AND METHODS 
Reagents, media, and growth conditions. All bacterial strains and plasmids utilized in this 
study are listed in Table 2. Bacterial strains were grown at 37°C with shaking at 250 rpm. S. 
aureus bacterial strains were grown in tryptic soy broth (TSB) or on tryptic soy agar (TSA), 
while Escherichia coli was grown in lysogeny broth (LB) or on LB agar. TSB supplemented 
with 5% human plasma was utilized for biofilm experiments. Some investigations required the 
use of antibiotics for selection, which were added at the following concentrations for S. aureus: 
erythromycin and tetracycline, 5 μg/ml; lincomycin, 25 μg/ml; and chloramphenicol, 10 μg/ml. 
For E. coli strains, ampicillin was used at a concentration of 100 μg/ml. When necessary, X-Gal 
(5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside) was utilized at a concentration of 40 μg/ml. 
The induction of complementation was achieved using 0.4 μM cadmium chloride (CdCl2) to 
induce protein expression. Throughout this study, strains were grown overnight, followed by a 
1:100 dilution into fresh TSB and additional growth for 3 h. Strains were then standardized to the 
optical density at 600 nm (OD600) required for each experiment (detailed below). 
 
  
TABLE 2. Strains and plasmids used in this study 
Strain or plasmid Genotype/propertiesa Reference 
or source 
Strains 
  
 E. coli DH5α Cloning strain 67 
 S. aureus 
  
   RN4220 Restriction-deficient strain Lab stock 
   AH1263 USA300 LAC CA-MRSA Erms 68 
   NE1262 USA300 JE2 mroQ::Tn::Erm, mroQ mutant 31 
   USF2299 USA300 LAC mroQ::Tn::Erm, mroQ mutant This study 
   SMM2502 USA300 LAC mroQ::Tn::Tet, mroQ mutant This study 
   SH1001 SH1000 agr::Tet, agr mutant 61 
   SMM2601 USA300 LAC agr::Tet, agr mutant This study 
   MJH502 SH1000 sigB::Tet, sigB mutant 61 
   SMM2602 USA300 LAC sigB::Tet, sigB mutant This study 
   LES02 SH1000/pAZ106::aur-lacZ (Ermr) 60 
   SMM2584 USA300 LAC/pAZ106::aur-lacZ (Ermr) This study 
   SMM2585 USA300 LAC mroQ::Tn::Tet/pAZ106::aur-lacZ (Ermr), mroQ mutant This study 
   SMM2586 USA300 LAC agr::Tet/pAZ106::aur-lacZ (Ermr), agr mutant This study 
   JLA371 SH1000/pAZ106::hla-lacZ (Ermr) 61 
   SMM2529 USA300 LAC/pAZ106::hla-lacZ (Ermr) This study 
   SMM2530 USA300 LAC mroQ::Tn::Tet/pAZ106::hla-lacZ (Ermr), mroQ mutant This study 
   SMM2531 USA300 LAC agr::Tet/pAZ106::hla-lacZ (Ermr), agr mutant This study 
   SMM2506 USA300 LAC mroQ::Tn::Tet/pJB67::mroQ, mroQ+ This study 
   SMM2507 USA300 LAC mroQ::Tn::Tet/pJB67::mroQ-His6, mroQ+ This study 
   SMM2508 USA300 LAC mroQ::Tn::Tet/pJB67::mroQ-E141A/E142A, mroQ+ catalytically inert mutant This study 
   SMM2509 USA300 LAC pEPSA5, LAC WT empty vector This study 
   SMM2510 USA300 LAC mroQ::Tn::Tet/pEPSA5, mroQ mutant empty vector This study 
   SMM2511 USA300 LAC agr::Tet/pEPSA5, agr mutant empty vector This study 
   SMM2516 USA300 LAC mroQ::Tn::Tet/pEPSA5::mroQ, mroQ+ This study 
   SMM2591 USA300 LAC pJB67, LAC WT empty vector This study 
   SMM2592 USA300 LAC mroQ::Tn::Tet/pJB67, mroQ mutant empty vector This study 
   SMM2593 USA300 LAC agr::Tet/pJB67, agr mutant empty vector This study 
   SMM2594 USA300 LAC sigB::Tet/pJB67, sigB mutant empty vector This study 
Plasmids 
  
  pTET Plasmid for tetracycline resistance cassette switch via allelic exchange and homologous recombination 31 
  pJB67 pCN51 with optimized RBS and Cd-inducible promoter, Ampr Ermr 59 
  pSMM01 pJB67::mroQ This study 
  pSMM02 pJB67::mroQ-E141A/E142A This study 
  pSMM03 pJB67::mroQ-His6 This study 
  pEPSA5 Xylose inducible shuttle vector, Ampr Camr 69 
  pSMM04 pEPSA5::mroQ This study 
a Erm, erythromycin; Tet, tetracycline; Amp, ampicillin; Cam, chloramphenicol; RBS, ribosome binding site. 
 
Mutant strain construction. A mroQ mutant was obtained from the Nebraska Transposon 
Mutant Library (NTML) (31). The USA300 JE2 SAUSA300_1984 transposon mutant was used 
to create a phage lysate using the phi11 bacteriophage (ϕ11), which was subsequently transduced 
into the S. aureus USA300 LAC background and confirmed by PCR using gene-specific primers 
(Table 3). Antibiotic resistance cassette switching for the mroQ mutant, from erythromycin to 
tetracycline, was achieved via allelic exchange and homologous recombination, as described by 
Bose and coworkers (31). These manipulations were again confirmed via PCR, followed by 
transduction into a clean USA300 LAC background (and a subsequent round of PCR 
confirmation). Additionally, the SH1000 agr and SH1000 sigB mutants were used to create 
phage lysates for transduction into the S. aureus USA300 LAC background. 
 
TABLE 3. Primers used in this study 
Primer Sequencea Descriptionb 
OL398 TCCTACGGGAGGCAGCAGT F 16S rRNA 
OL399 GGACTACCAGGGTATCTAATCCTGTT R 16S rRNA 
OL1184 AGCCGACCTGAGAGGGTGA F 16S rRNA qPCR 
OL1185 TCTGGACCGTGTCTCAGTTCC R 16S rRNA qPCR 
OL1232 CGCCACATATCCTGATCTTCCAGA R pAZ106 screening 
primer 
OL2123 GAGTTGTTATCAATGGTCAC F sarA qPCR 
OL2124 ACTGCTTTAACAACTTGTGG R sarA qPCR 
OL2483 CGGCTTCATTCAAAGTC F spa qPCR 
OL2484 GTGCTTGAGATTCGTTTA R spa qPCR 
OL2487 TAGTGGTCCATCAACAG F lukS-PV qPCR 
OL2488 ACGTTCTACTTCACTGATA R lukS-PV qPCR 
OL2495 AACAATCGGATTTAGTACAG F sarS qPCR 
OL2496 GTAAGTATTACGCTCATCAA R sarS qPCR 
OL2536 AGTTTGCCACGTATCTT F agrB qPCR 
OL2537 TTAGCTAAGACCTGCATC R agrB qPCR 
OL2540 TTAAGGAAGGAGTGATTTC F RNAIII gene qPCR 
OL2541 GTTCACTGTGTCGATAAT R RNAIII gene qPCR 
OL3116 ACCACAATAACTCAAATTCCTTAATACG F saeR qPCR 
OL3117 GTTGAACAACTGTCGTTTGATGA R saeR qPCR 
OL3166 CGCGAACGAGAAATCATACAATG F sigB qPCR 
OL3167 TCTCTGAAGTCGTGATACATGC R sigB qPCR 
OL3612 GGTCCTTTATTAGCAGCATATGTATTCAG F E141A/E142A site-
directed mutagenesis 
OL3613 CTGAATACATATGCTGCTAATAAAGGACC R E141A/E142A site-
directed mutagenesis 
OL3749 GTAGTTGTAGGTAAAGATACTC F sspA qPCR 
OL3750 CCATTTGGATAATTGTCTTG R sspA qPCR 
OL3777 ATGgaattcTTAGTGGTGGTGGTGGTGGTGTGGAATAAAAATGTGATATATAAAATTCGC R mroQ 6×His tag 
OL4011 CTAGGTGAATATGCTGCTACAG F codY qPCR 
OL4012 CCATTGTAATAGCAGCTTTATCG R codY qPCR 
OL4047 GCTCAAAGACAAGTTAATCGCTAC F mgrA qPCR 
OL4048 CGTTTACAGGAGATTCATCCCA R mgrA qPCR 
OL4049 CAAAGTTGCTGGGCTTGATTAC F arlR qPCR 
OL4050 TTTGTGGCTGACGACGTAAA R arlR qPCR 
OL4051 TTCGAACACGTGAAGAGAAAGA F sarZ qPCR 
OL4052 CTGATGCTTCTCGTTCTGAAATG R sarZ qPCR 
OL4053 CGGTAAAGAATTGAGGGATACATTACAT F sarV qPCR 
OL4054 CTTGTCTTTCATCCGTTTCAGAAC R sarV qPCR 
OL4055 CGATGAAGCATTGCAAAGATGA F sarX qPCR 
OL4056 GTCCTACTTAAATCTAGCTCATCCA R sarX qPCR 
Primer Sequencea Descriptionb 
OL4093 GGCAGATAATGATGATCGC F pJB67 MCS 
OL4094 CATGTCAACGATAATACAAAATATAATAC R pJB67 MCS 
OL4139 ATGcccgggATGACAAGATTATGGGCATCATTGC F mroQ for pJB67 
OL4140 ATGgaattcCATGCTATTCTTATTTGTAAAGCGAAATAAAAA R mroQ for pJB57 
OL4332 ATGgaattcATGACAAGATTATGGGCATCATTGC F mroQ for pEPSA5 
OL4333 ATGggatccCATGCTATTCTTATTTGTAAAGCGAAATAAAAA R mroQ for pEPSA5 
OL4358 CTCGGACCGTCATAAAAAATTTATTTGC F pEPSA5 MCS 
OL4359 CGGCGTTTCACTTCTGAGTTCGGCATGG R pEPSA5 MCS 
OL4445 AACTGTTCTTTCGTCTTGTAAACT F sarR qPCR 
OL4446 TGCTCAGAGTTCAAACCTTACT R sarR qPCR 
OL4545 TCACCAGTAGAACCAACAAAGG F lip qPCR 
OL4546 GTAACGTTGCTACTGCACTACT R lip qPCR 
OL4547 GGTATCATCGCTGGCAT F psmα1 qPCR 
OL4548 TTTACCAGTGAATTGTTCGATTAAG R psmα1 qPCR 
OL4620 GTATCAAGTTCAAGGTGAGAAT F rsr qPCR 
OL4621 GGCCATTCATATCTACATTCATA R rsr qPCR 
OL4622 TAGAGACCCACATGATAGTA F sarT qPCR 
OL4623 GTTTCATTAATATTTATTTCACTCA R sarT qPCR 
OL4624 CAGTTACTCCAATACAACGTAAA F sarU qPCR 
a Restriction sites are noted by underlined lowercase letters. Italics denotes site-directed mutations. Bold indicates an 
included hexahistidine tag. 
b F, forward; R, reverse. 
 
Complementation of the mroQ mutation. An mroQ-complementing PCR fragment was created 
using primers OL4139 and OL4140 (all primers used are listed in Table 3), with the former 
being located immediately at the mroQ start codon and the latter being located 88 bp downstream 
of the 3′ end of the coding region. We also performed site-directed mutagenesis to create a 
catalytically inert complementing fragment, using splicing by overhang extension (SOE) PCR 
techniques as previously described by us (58). This was generated using primers 
OL4139/OL3613 and OL3612/OL4140, where OL3612 and OL3613 contained mutated 
nucleotide sequences that change the native GAAGAA sequence encoding two glutamic acid 
residues to a GCAGCA sequence encoding two alanine residues. To facilitate Western blot 
analysis, a hexahistidine (6×His) tag was added to primer OL4140, creating OL3777, which was 
used along with OL4139 to create a tagged fragment for localization studies. Each of these 
three mroQ fragments was separately cloned into pJB67, a multicopy plasmid with a CdCl2-
inducible promoter and ribosome binding site (59). An additional mroQ-complementing strain 
was created using primers OL4332 and OL4333, which are identical to primers OL4139 and 
OL4140, with the exception of the presence of different restriction sites that were compatible 
with pEPSA5, a xylose-inducible shuttle vector. 
 
All constructs were transformed into chemically competent E. coli (DH5α) cells, with clones 
being confirmed using gene-specific primers, followed by Sanger sequencing (Eurofins MWG 
Operon). Plasmids bearing the correct sequence were transformed into S. aureus RN4220 by 
electroporation and confirmed by PCR. Following this, a phage lysate was created using ϕ11, 
which was subsequently used to transduce the S. aureus USA300 LAC mroQ mutant. Strains 
were confirmed via Sanger sequencing using plasmid-specific primers. Additionally, the pJB67 
empty vector was transformed into S. aureus RN4220 by electroporation and confirmed by PCR. 
A phage lysate was created using ϕ11, which was then used to transduce the S. aureus USA300 
LAC wild type, USA300 LAC mroQ mutant, USA300 LAC agr mutant, and USA300 
LAC sigB mutant, to serve as negative controls. Strains were subsequently confirmed via PCR 
with plasmid-specific primers OL4093 and OL4094. These control strains were also created with 
the pEPSA5 empty vector, as described above, and confirmed via PCR with plasmid-specific 
primers OL4358 and OL4359. 
 
Construction of lacZ-reporter fusion strains. hla-lacZ and aur-lacZ fusion strains were 
previously constructed using plasmid pAZ106 (60, 61). Phage lysates were created from SH1000 
pAZ106::aur-lacZ and SH1000 pAZ106::hla-lacZ strains using ϕ11, before transducing both 
separately into the USA300 LAC wild type, alongside its mroQ and agr mutant strains. 
Following this, strains containing fusions were confirmed via PCR using a reverse primer located 
downstream of the multiple-cloning site (MCS) and within the lacZ gene, OL1232, and the 
fusion’s respective forward primer. 
 
β-Galactosidase assays. The levels of β-galactosidase activity for the aur-lacZ and hla-lacZ 
fusions were quantified as described previously (60). Assays were performed in biological 
triplicate and technical duplicate. Strains were grown as described above and standardized to an 
OD600 of 0.05. Samples were taken every hour for 6 h and processed using 4-methylumbelliferyl 
beta-d-galactopyranoside (4-MUG) as a substrate. Student's t test with Welch’s correction was 
used to determine statistical significance. 
 
Zymogram and Western blot analysis. Zymograms were performed as previously described 
(60), using culture supernatants from strains grown for 15 h. The OD600s of these cultures were 
standardized to the lowest value among the collection, before being concentrated using Amicon 
Ultra-2 centrifugal 3-kDa filter units (Millipore Sigma). For Western blot analysis, overnight 
bacterial cultures were grown in biological triplicate as described above, standardized to an 
OD600 of 0.05, and grown to the appropriate time points. Secreted (5 h) and insoluble (3 h) 
protein fractions were harvested as previously described (62) before being run on 12% SDS-
PAGE gels. Samples were subsequently blotted to polyvinylidene difluoride membranes as 
previously described (33). Immunoblotting was performed with an anti-protein A mouse 
monoclonal primary antibody (SPA-27; Sigma-Aldrich) or an anti-LukS-PV mouse monoclonal 
primary antibody (IBT) overnight at 4°C. The secondary antibody used was horseradish 
peroxidase (HRP)-conjugated goat anti-mouse IgG (Cell Signaling Technologies). For 
localization studies, the mroQ-6×His-complemented strain was grown overnight in biological 
triplicate as described above. Next, 1 ml of bacterial culture was centrifuged, and supernatants 
were collected and concentrated overnight using 10% trichloroacetic acid (TCA), with the pellet 
being processed as previously described (62) to harvest the various protein fractions 
(cytoplasmic and membrane). Samples were prepared for immunoblotting as described above, 
and immunoblotting was performed using anti-6×His oligoclonal rabbit primary antibody 
(Thermo Fisher Scientific) overnight at 4°C. The secondary antibody used was HRP-conjugated 
goat anti-rabbit IgG (Cell Signaling Technologies). HRP activity was assessed using the 
SuperSignal West Pico Chemiluminescent substrate (Thermo Fisher Scientific) and visualized on 
X-ray film. 
 
Hemolysis assay. Overnight bacterial cultures were grown in biological triplicate as described 
above and standardized to an OD600 of 0.05. Cultures were incubated for 6 h before being 
centrifuged, and the supernatant was removed and mixed (1:1) with hemolysin buffer (0.145 M 
NaCl, 20 mM CaCl2), followed by the addition of 25 μl whole human blood (BioIVT). Samples 
were incubated for 40 min at 37°C on a rotator, before being centrifuged at 5.5 × g for 1 min. 
Supernatants were collected and hemolysis was determined by measuring the OD543 using a 
BioTek Synergy II plate reader and 96-well plates. Student's t test with Welch’s correction was 
used to determine statistical significance. 
 
qPCR analysis. Quantitative real-time PCR (qPCR) was performed on samples isolated at hour 
5 in biological triplicate as previously described (63). Various targets were examined, and their 
levels of expression were normalized to that of 16S rRNA (the primers used are listed in Table 
3). Student's t test with Welch’s correction was used to determine the statistical significance of 
the expression units. 
 
Transcriptomic analysis via RNA sequencing. RNA-seq was performed as previously 
described (64). Briefly, cultures of the USA300 LAC wild type, alongside its mroQ and agr 
mutant strains, were standardized and grown in biological triplicate for 5 h using the growth 
method described above. Next, 5 ml of each culture was immediately combined with 5 ml of ice-
cold phosphate-buffered saline (PBS) and pelleted by centrifugation at 4°C, and the supernatant 
was removed. Total RNA was isolated using an RNeasy kit (Qiagen), with the DNA removed 
using a Turbo DNA-free kit (Ambion). DNA removal was confirmed by PCR using primers 
OL398 and OL399, and RNA quality was assessed using an Agilent 2100 bioanalyzer and an 
RNA 6000 Nano kit (Agilent) to confirm integrity; samples with an RNA integrity number (RIN) 
of greater than 9.7 were used. Biological replicates were pooled at equal RNA concentrations, 
before rRNA depletion using a Ribo-Zero kit for Gram-positive bacteria (Illumina) and a 
MICROBExpress bacterial mRNA enrichment kit (Ambion). The removal efficiency was 
confirmed, again using an Agilent 2100 bioanalyzer and RNA 6000 Nano kit. Strand-specific 
library preparation was performed using a total RNA-seq kit (v2) and whole-transcriptome 
protocol (Ion Torrent). Sample libraries were assessed for quality, concentration, and average 
fragment size using the Agilent 2100 bioanalyzer and a high-sensitivity DNA kit (Agilent). 
Prepared fragment libraries were ligated to Ion Sphere particles, amplified, and enriched using an 
Ion Torrent personal genome machine (OT2 200) kit and Ion OneTouch 2 system. Particles were 
then sequenced using an Ion 318 (v2) chip (Ion Torrent). 
 
Bioinformatics. Raw data (.fasta) files were exported from the Ion Torrent PGM system server 
using the File Exporter plug-in and uploaded to the Qiagen Bioinformatics Workbench for 
analysis. Reads corresponding to rRNA were filtered, removed by aligning to known rRNA 
sequences, and discarded. Unmapped (filtered) read sequences were aligned to the USA300 
FPR3757 reference genome (GenBank accession number NC_007793.1), and expression values 
were calculated using the RNA-Seq Analysis function. Experimental comparisons were carried 
out following quantile normalization by use of the RNA-seq experimental fold change feature. 
Expression values calculated for each gene are shown as normalized reads per kilobase per 
million values. 
 
Biofilm formation assay. The ability of our strains to form biofilms was examined using 
methods previously described (33). Overnight bacterial cultures were grown in biological 
triplicate as described above and standardized to an OD600 of 0.5. Cultures were then seeded in a 
24-well plate containing TSB, 5% human plasma, and erythromycin for plasmid retention in 
technical duplicate and grown for 24 h. Following incubation, the biofilms were washed with 
PBS and briefly fixed with 100% ethanol. The biofilms were then allowed to dry overnight prior 
to staining with crystal violet for 15 min. Following this, the wells were washed to remove 
excess crystal violet and allowed to dry overnight. Biofilm formation was quantified by 
extracting crystal violet stain with 100% ethanol and measuring the OD550 using a BioTek 
Synergy II plate reader. Student's t test with Welch’s correction was used to determine statistical 
significance. 
 
Oxidative stress assay. Overnight bacterial cultures were grown in biological triplicate as 
described above and standardized to an OD600 of 0.1. Samples were treated with 20 mM 
hydrogen peroxide for 30 min with shaking at 37°C. After this time, the reaction was stopped by 
the addition of 10 μg/ml catalase. Percent recovery was determined by comparing the number of 
CFU per milliliter preexposure to the number of CFU per milliliter postexposure. Student's t test 
with Welch’s correction was used to determine statistical significance. 
 
Murine model of sepsis and dissemination. The murine model of sepsis and dissemination was 
performed as previously described (65). Briefly, 6-week old, female CD-1 mice were purchased 
from Charles River Laboratories and allowed to acclimate for 1 week prior to the start of 
experimentation. Wild-type and mutant strains were grown as described above and standardized 
to an OD600 of 0.05. Cultures were grown overnight for 15 h on three separate days, and the 
average number of CFU per milliliter across replicates was calculated for each strain. This 
average number of CFU per milliliter was used to determine the volume of bacteria needed to 
obtain a 10-ml inoculum of 5 × 108 ([5 × 108/average CFU/ml] × 10 ml). On the day of infection, 
appropriate aliquots from fresh overnight cultures prepared in the same way were centrifuged, 
resuspended in 1 ml sterile PBS to wash, centrifuged once more, and finally, resuspended in a 
total volume of 10 ml sterile PBS. Next, 100 μl of the bacterial suspension was administered via 
tail vein injection, providing a final inoculum of 5 × 107 CFU/ml. Infections were monitored over 
a 7-day period or until the mice reached a premoribund state, at which point they were 
euthanized (65). At this time, kidneys were harvested and stored at −80°C. These were 
subsequently photographed before being homogenized in 1 ml PBS and serially diluted onto 
TSA to determine the bacterial burden (number of CFU per milliliter). A Mann-Whitney test was 
performed to determine statistical significance for the bacterial burden in kidneys. 
 
Murine model of skin abscess formation. The murine model of skin abscess formation was 
performed as described previously (66). Briefly, wild-type and mutant strains were grown for 
2.5 h until reaching an OD600 of approximately 0.75. Bacterial cells were centrifuged, and the 
pellet was resuspended in sterile PBS for inoculation. Inocula were prepared at 
1 × 107 CFU/50 μl for injections and subsequently confirmed via serial dilution and plating. Six-
week-old BALB/c female mice were shaved on the right flank prior to treatment with Nair for 
full hair removal. Subsequently, mice were injected in the right flank with 50 μl, and infections 
were allowed to persist for 7 days. Throughout the infection period, the mice were monitored for 
irregular activity or distress. Following the 7-day infection period, mice were euthanized and the 
abscesses were excised, weighed, and measured (length and width) to determine the abscess area 
(in square millimeters). The abscesses were then homogenized, and homogenates were diluted 
and plated onto TSA to determine the bacterial burden (number of CFU per gram). 
Student's t test with Welch’s correction was used to determine statistical significance. 
 
Mass spectrometry of culture supernatants for AIP-I detection. The wild-type, mroQ 
mutant, agr mutant, and pEPSA5::mroQ -complemented strains were grown for 15 h in TSB 
supplemented with 1% xylose as described above. The cultures were pelleted, and the 
supernatants were filter sterilized (pore size, 0.2 μm) to ensure that they were cell free. Samples 
were then processed by the Triad Mass Spectrometry Facility at The University of North 
Carolina—Greensboro, alongside controls of TSB and purified AIP-I (AnaSpec Inc., Fremont, 
CA). Samples were analyzed using an Acquity UPLC (Waters, Milford, MA) coupled to a TSQ 
Quantum Access triple-quadrupole mass spectrometer (Thermo, San Jose, CA) with a heated 
electrospray ionization (HESI) source. A 5-μl injection of each sample was eluted from an 
Acquity BEH C18 column (2.1 mm by 50 mm, 1.8-μm-particle-size packing) using a binary 
solvent system consisting of Optima-grade water and Optima-grade acetonitrile (both containing 
0.1% formic acid) at a flow rate of 300 μl/min. The gradient initiated at 75:25 water-acetonitrile 
and increased linearly to 50:50 water-acetonitrile over 3.5 min. The column was then washed 
with 100% acetonitrile and reequilibrated to starting conditions. The mass spectrometer was 
operated in multiple-reaction-monitoring mode using positive ion electrospray ionization. 
Transitions of m/z 961.3 ([M+H]+) to m/z 711.2 and m/z 961.3 to m/z 365.9 were monitored at a 
gas pressure of 1.5 and a collision energy of 29 and 43, respectively. Quantitative analysis was 
performed using the m/z 961.3-to-711.2 transition. The HESI source was operated using the 
following parameters: tube lens offset, 198 V; spray voltage, 5.00 kV; sheath gas pressure, 60; 
auxiliary gas pressure, 35; capillary temperature, 200°C; and capillary offset, 35 V. 
 
Ethics statement. All animal work was performed under the approval of the University of South 
Florida's Institutional Animal Care and Use Committee (IACUC) and Ohio University's IACUC 
by trained lab personnel. 
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Expression Omnibus (GEO) database (GEO accession number GSE121625). 
 
Supplemental material. Supplemental material for this article may be found at 
https://doi.org/10.1128/IAI .00002-19. 
 
ACKNOWLEDGMENTS 
 
This work was supported in part by grants AI080626 and AI124458 (both to L.N.S.) from the 
National Institute of Allergy and Infectious Diseases and by grant AT006860 from the National 
Center for Complementary and Integrative Health (to N.B.C. and D.A.T.). 
REFERENCES 
1. Balasubramanian D, Harper L, Shopsin B, Torres VJ. 2017. Staphylococcus aureus 
pathogenesis in diverse host environments. Pathog Dis 75:1ftx005. 
https://doi.org/10.1093/femspd/ftx005. 
 
2. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong Y-Q. 2004. Regulation of virulence 
determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 
40:1–9. https://doi.org/10.1016/S0928-8244(03)00309-2. 
 
3. Foster TJ, Hook M. 1998. Surface protein adhesins of Staphylococcus aureus. Trends 
Microbiol 6:484 – 488. https://doi.org/10.1016/S0966-842X(98)01400-0. 
 
4. Thomer L, Schneewind O, Missiakas D. 2016. Pathogenesis of Staphylococcus aureus 
bloodstream infections. Annu Rev Pathol 11:343–364. https://doi.org/10.1146/annurev-pathol-
012615-044351. 
 
5. Reyes D, Andrey DO, Monod A, Kelley WL, Zhang G, Cheung AL. 2011. Coordinated 
regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus. J 
Bacteriol 193:6020–6031. https://doi.org/10.1128/JB.05436-11. 
 
6. Ballal A, Ray B, Manna AC. 2009. sarZ, a sarA family gene, is transcriptionally activated by 
MgrA and is involved in the regulation of genes encoding exoproteins in Staphylococcus aureus. 
J Bacteriol 191:1656–1665. https://doi.org/10.1128/JB.01555-08. 
 
7. Manna AC, Cheung AL. 2006. Expression of SarX, a negative regulator of agr and exoprotein 
synthesis, is activated by MgrA in Staphylococcus aureus. J Bacteriol 188:4288–4299. 
https://doi.org/10.1128/JB.00297-06. 
 
8. Fournier B, Klier A, Rapoport G. 2001. The two-component system ArlS-ArlR is a regulator 
of virulence gene expression in Staphylococcus aureus. Mol Microbiol 41:247–261. 
https://doi.org/10.1046/j.1365-2958.2001.02515.x. 
 
9. Cheung AL, Schmidt K, Bateman B, Manna AC. 2001. SarS, a SarA homolog repressible by 
agr, is an activator of protein A synthesis in Staphylococcus aureus. Infect Immun 69:2448 –
2455. https://doi.org/10.1128/IAI.69.4.2448-2455.2001. 
 
10. Clarke SR, Foster SJ. 2006. Surface adhesins of Staphylococcus aureus. Adv Microb Physiol 
51:187–224. https://doi.org/10.1016/S0065-2911(06)51004-5. 
 
11. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, 
Li M, Otto M. 2008. RNAIII-independent target gene control by the agr quorum-sensing system: 
insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 32:150 –
158. https://doi.org/10.1016/j.molcel.2008.08.005. 
 
12. Gray B, Hall P, Gresham H. 2013. Targeting agr- and agr-like quorum sensing systems for 
development of common therapeutics to treat multiple gram-positive bacterial infections. 
Sensors (Basel) 13:5130–5166. https://doi.org/10.3390/s130405130. 
 
13. Boisset S, Geissmann T, Huntzinger E, Fechter P, Bendridi N, Possedko M, Chevalier C, 
Helfer AC, Benito Y, Jacquier A, Gaspin C, Vandenesch F, Romby P. 2007. Staphylococcus 
aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription 
regulator Rot by an antisense mechanism. Genes Dev 21:1353–1366. 
https://doi.org/10.1101/gad.423507. 
 
14. Wang B, Zhao A, Novick RP, Muir TW. 2014. Activation and inhibition of the receptor 
histidine kinase AgrC occurs through opposite helical transduction motions. Mol Cell 53:929 –
940. https://doi.org/10.1016/j.molcel.2014.02.029. 
 
15. Thoendel M, Horswill AR. 2013. Random mutagenesis and topology analysis of the 
autoinducing peptide biosynthesis proteins in Staphylococcus aureus. Mol Microbiol 87:318 –
337. https://doi.org/10.1111/mmi.12100. 
 
16. George Cisar EA, Geisinger E, Muir TW, Novick RP. 2009. Symmetric signalling within 
asymmetric dimers of the Staphylococcus aureus receptor histidine kinase AgrC. Mol Microbiol 
74:44 –57. https://doi.org/10.1111/j.1365-2958.2009.06849.x. 
 
17. Tamber S, Cheung AL. 2009. SarZ promotes the expression of virulence factors and 
represses biofilm formation by modulating SarA and agr in Staphylococcus aureus. Infect 
Immun 77:419–428. https://doi.org/10.1128/IAI.00859-08. 
 
18. Shaw LN, Aish J, Davenport JE, Brown MC, Lithgow JK, Simmonite K, Crossley H, Travis 
J, Potempa J, Foster SJ. 2006. Investigations into sigmaB-modulated regulatory pathways 
governing extracellular virulence determinant production in Staphylococcus aureus. J Bacteriol 
188:6070–6080. https://doi.org/10.1128/JB.00551-06. 
 
19. Andrey DO, Jousselin A, Villanueva M, Renzoni A, Monod A, Barras C, Rodriguez N, 
Kelley WL. 2015. Impact of the regulators SigB, Rot, SarA and sarS on the toxic shock Tst 
promoter and TSST-1 expression in Staphylococcus aureus. PLoS One 10:e0135579. 
https://doi.org/10.1371/journal.pone.0135579. 
 
20. Roux A, Todd DA, Velazquez JV, Cech NB, Sonenshein AL. 2014. CodY-mediated 
regulation of the Staphylococcus aureus Agr system integrates nutritional and population density 
signals. J Bacteriol 196:1184–1196. https://doi.org/10.1128/JB.00128-13. 
 
21. Sterba KM, Mackintosh SG, Blevins JS, Hurlburt BK, Smeltzer MS. 2003. Characterization 
of Staphylococcus aureus SarA binding sites. J Bacteriol 185:4410–4417. 
https://doi.org/10.1128/JB.185.15.4410-4417.2003. 
 
22. Fechter P, Caldelari I, Lioliou E, Romby P. 2014. Novel aspects of RNA regulation in 
Staphylococcus aureus. FEBS Lett 588:2523–2529. 
https://doi.org/10.1016/j.febslet.2014.05.037. 
 
23. Painter KL, Krishna A, Wigneshweraraj S, Edwards AM. 2014. What role does the quorum-
sensing accessory gene regulator system play during Staphylococcus aureus bacteremia? Trends 
Microbiol 22:676–685. https://doi.org/10.1016/j.tim.2014.09.002. 
 
24. Chopin MC, Chopin A, Bidnenko E. 2005. Phage abortive infection in lactococci: variations 
on a theme. Curr Opin Microbiol 8:473– 479. https://doi.org/10.1016/j.mib.2005.06.006. 
 
25. Kjos M, Snipen L, Salehian Z, Nes IF, Diep DB. 2010. The Abi proteins and their 
involvement in bacteriocin self-immunity. J Bacteriol 192:2068–2076. 
https://doi.org/10.1128/JB.01553-09. 
 
26. Pei J, Grishin N. 2001. Type II CAAX prenyl endopeptidases belong to a novel superfamily 
of putative membrane-bound metalloproteases. Trends Biomed Sci 26:275–277. 
https://doi.org/10.1016/S0968-0004(01)01813-8. 
 
27. Firon A, Tazi A, Da Cunha V, Brinster S, Sauvage E, Dramsi S, Golenbock DT, Glaser P, 
Poyart C, Trieu-Cuot P. 2013. The Abi-domain protein Abx1 interacts with the CovS histidine 
kinase to control virulence gene expression in group B Streptococcus. PLoS Pathog 9:e1003179. 
https://doi.org/10.1371/journal.ppat.1003179. 
 
28. Krute CN, Carroll RK, Rivera FE, Weiss A, Young RM, Shilling A, Botlani M, Varma S, 
Baker BJ, Shaw LN. 2015. The disruption of prenylation leads to pleiotropic rearrangements in 
cellular behavior in Staphylococcus aureus. Mol Microbiol 95:819–832. 
https://doi.org/10.1111/mmi.12900. 
 
29. Okada M. 2011. Post-translational isoprenylation of tryptophan. Biosci Biotechnol Biochem 
75:1413–1417. https://doi.org/10.1271/bbb.110087. 
 
30. Poupel O, Proux C, Jagla B, Msadek T, Dubrac S. 2018. SpdC, a novel virulence factor, 
controls histidine kinase activity in Staphylococcus aureus. PLoS Pathog 14:e1006917. 
https://doi.org/10.1371/journal.ppat.1006917. 
 
31. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A 
genetic resource for rapid and comprehensive phenotype screening of nonessential 
Staphylococcus aureus genes. mBio 4:e00537-12. https://doi.org/10.1128/mBio.00537-12. 
 
32. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. 2004. Quorum sensing in 
Staphylococcus aureus biofilms. J Bacteriol 186:1838 –1850. 
https://doi.org/10.1128/JB.186.6.1838-1850.2004. 
 
33. Weiss A, Moore BD, Tremblay MH, Chaput D, Kremer A, Shaw LN. 2017. The omega 
subunit governs RNA polymerase stability and transcriptional specificity in Staphylococcus 
aureus. J Bacteriol 199:e00459-16. https://doi.org/10.1128/JB.00459-16. 
 
34. Boles BR, Horswill AR. 2008. Agr-mediated dispersal of Staphylococcus aureus biofilms. 
PLoS Pathog 4:e1000052. https://doi.org/10.1371/journal.ppat.1000052. 
 
35. Frankel MB, Wojcik BM, DeDent AC, Missiakas DM, Schneewind O. 2010. ABI domain-
containing proteins contribute to surface protein display and cell division in Staphylococcus 
aureus. Mol Microbiol 78:238 –252. https://doi.org/10.1111/j.1365-2958.2010.07334.x. 
 
36. Junio HA, Todd DA, Ettefagh KA, Ehrmann BM, Kavanaugh JS, Horswill AR, Cech NB. 
2013. Quantitative analysis of autoinducing peptide I (AIP-I) from Staphylococcus aureus 
cultures using ultrahigh performance liquid chromatography-high resolving power mass 
spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 930:7–12. 
https://doi.org/10.1016/j.jchromb.2013.04.019. 
 
37. Cregg KM, Wilding I, Black MT. 1996. Molecular cloning and expression of the spsB gene 
encoding an essential type I signal peptidase from Staphylococcus aureus. J Bacteriol 178:5712–
5718. https://doi.org/10.1128/jb.178.19.5712-5718.1996. 
 
38. Kavanaugh JS, Thoendel M, Horswill AR. 2007. A role for type I signal peptidase in 
Staphylococcus aureus quorum sensing. Mol Microbiol 65:780 –798. 
https://doi.org/10.1111/j.1365-2958.2007.05830.x. 
 
39. Nygaard TK, Pallister KB, Ruzevich P, Griffith S, Vuong C, Voyich JM. 2010. SaeR binds a 
consensus sequence within virulence gene promoters to advance USA300 pathogenesis. J Infect 
Dis 201:241–254. https://doi.org/10.1086/649570. 
 
40. Cheng AG, DeDent AC, Schneewind O, Missiakas D. 2011. A play in four acts: 
Staphylococcus aureus abscess formation. Trends Microbiol 19: 225–232. 
https://doi.org/10.1016/j.tim.2011.01.007. 
 
41. Malachowa N, Kobayashi SD, Braughton KR, DeLeo FR. 2013. Mouse model of 
Staphylococcus aureus skin infection. Methods Mol Biol 1031: 109–116. 
https://doi.org/10.1007/978-1-62703-481-4_14. 
 
42. Thurlow LR, Joshi GS, Richardson AR. 2012. Virulence strategies of the dominant USA300 
lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). 
FEMS Immunol Med Microbiol 65:5–22. https://doi.org/10.1111/j.1574-695X.2012.00937.x. 
 
43. Kim HK, Missiakas D, Schneewind O. 2014. Mouse models for infectious diseases caused 
by Staphylococcus aureus. J Immunol Methods 410:88–99. 
https://doi.org/10.1016/j.jim.2014.04.007. 
 
44. Beenken KE, Mrak LN, Griffin LM, Zielinska AK, Shaw LN, Rice KC, Horswill AR, Bayles 
KW, Smeltzer MS. 2010. Epistatic relationships between sarA and agr in Staphylococcus aureus 
biofilm formation. PLoS One 5:e10790. https://doi.org/10.1371/journal.pone.0010790. 
 
45. Luong TT, Dunman PM, Murphy E, Projan SJ, Lee CY. 2006. Transcription profiling of the 
mgrA regulon in Staphylococcus aureus. J Bacteriol 188:1899 –1910. 
https://doi.org/10.1128/JB.188.5.1899-1910.2006. 
 
46. Srivastava SK, Rajasree K, Fasim A, Arakere G, Gopal B. 2014. Influence of the AgrC-AgrA 
complex on the response time of Staphylococcus aureus quorum sensing. J Bacteriol 196:2876 –
2888. https://doi.org/10.1128/JB.01530-14. 
 
47. Plummer LJ, Hildebrandt ER, Porter SB, Rogers VA, McCracken J, Schmidt WK. 2006. 
Mutational analysis of the Ras converting enzyme reveals a requirement for glutamate and 
histidine residues. J Biol Chem 281:4596–4605. https://doi.org/10.1074/jbc.M506284200. 
 
48. Zhang FL, Casey PJ. 1996. Protein prenylation: molecular mechanisms and functional 
consequences. Annu Rev Biochem 65:241–269. 
https://doi.org/10.1146/annurev.bi.65.070196.001325. 
 
49. Burnside K, Lembo A, de Los Reyes M, Iliuk A, Binhtran NT, Connelly JE, Lin WJ, 
Schmidt BZ, Richardson AR, Fang FC, Tao WA, Rajagopal L. 2010. Regulation of hemolysin 
expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase. 
PLoS One 5:e11071. https://doi.org/10.1371/journal.pone.0011071. 
 
50. Gong J, Li D, Yan J, Liu Y, Li D, Dong J, Gao Y, Sun T, Yang G. 2014. The accessory gene 
regulator (agr) controls Staphylococcus aureus virulence in a murine intracranial abscesses 
model. Braz J Infect Dis 18:501–506. https://doi.org/10.1016/j.bjid.2014.03.005. 
 
51. Paharik AE, Horswill AR. 2016. The staphylococcal biofilm: adhesins, regulation, and host 
response. Microbiol Spectr 4:VMBF-0022-2015. https://doi.org/10.1128/microbiolspec.VMBF-
0022-2015. 
 
52. David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus 
aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 
23:616–687. https://doi.org/10.1128/CMR.00081-09. 
 
53. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, 
Schneewind O, DeLeo FR. 2010. Targeting of alphahemolysin by active or passive 
immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 
202:1050 –1058. https://doi.org/10.1086/656043. 
 
54. Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. 2011. 
Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 
2:445– 459. https://doi.org/10.4161/viru.2.5.17724. 
 
55. Walker JN, Crosby HA, Spaulding AR, Salgado-Pabon W, Malone CL, Rosenthal CB, 
Schlievert PM, Boyd JM, Horswill AR. 2013. The Staphylococcus aureus ArlRS two-component 
system is a novel regulator of agglutination and pathogenesis. PLoS Pathog 9:e1003819. 
https://doi.org/10.1371/journal.ppat.1003819. 
 
56. Montgomery CP, Boyle-Vavra S, Daum RS. 2010. Importance of the global regulators Agr 
and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One 5:e15177. 
https://doi.org/10.1371/journal.pone.0015177. 
 
57. Falord M, Mader U, Hiron A, Debarbouille M, Msadek T. 2011. Investigation of the 
Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell 
wall signal transduction pathways. PLoS One 6:e21323. 
https://doi.org/10.1371/journal.pone.0021323. 
 
58. Krute CN, Bell-Temin H, Miller HK, Rivera FE, Weiss A, Stevens SM, Shaw LN. 2015. The 
membrane protein PrsS mimics sigmaS in protecting Staphylococcus aureus against cell wall-
targeting antibiotics and DNA-damaging agents. Microbiology 161:1136 –1148. 
https://doi.org/10.1099/mic.0.000065. 
 
59. Windham IH, Chaudhari SS, Bose JL, Thomas VC, Bayles KW. 2016. SrrAB modulates 
Staphylococcus aureus cell death through regulation of cidABC transcription. J Bacteriol 
198:1114 –1122. https://doi.org/10.1128/JB.00954-15. 
 
60. Shaw L, Golonka E, Potempa J, Foster SJ. 2004. The role and regulation of the extracellular 
proteases of Staphylococcus aureus. Microbiology 150:217–228. 
https://doi.org/10.1099/mic.0.26634-0. 
 
61. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ. 2002. sigmaB modulates 
virulence determinant expression and stress resistance: characterization of a functional rsbU 
strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184:5457–5467. 
https://doi.org/10.1128/JB.184.19.5457-5467.2002. 
 
62. Rivera FE, Miller HK, Kolar SL, Stevens SM, Jr, Shaw LN. 2012. The impact of CodY on 
virulence determinant production in community-associated methicillin-resistant Staphylococcus 
aureus. Proteomics 12:263–268. https://doi.org/10.1002/pmic.201100298. 
 
63. Miller HK, Carroll RK, Burda WN, Krute CN, Davenport JE, Shaw LN. 2012. The 
extracytoplasmic function sigma factor sigmaS protects against both intracellular and 
extracytoplasmic stresses in Staphylococcus aureus. J Bacteriol 194:4342– 4354. 
https://doi.org/10.1128/JB.00484-12. 
 
64. Carroll RK, Weiss A, Shaw LN. 2014. RNA-sequencing of Staphylococcus aureus 
messenger RNA. Methods Mol Biol 1373:131–141. https://doi.org/10.1007/7651_2014_192. 
 
65. Kolar SL, Ibarra JA, Rivera FE, Mootz JM, Davenport JE, Stevens SM, Horswill AR, Shaw 
LN. 2013. Extracellular proteases are key mediators of Staphylococcus aureus virulence via the 
global modulation of virulence-determinant stability. Microbiologyopen 2:18 –34. 
https://doi.org/10.1002/mbo3.55. 
 
66. Keogh RA, Zapf RL, Wiemels RE, Wittekind MA, Carroll RK. 2018. The intracellular 
cyclophilin PpiB contributes to the virulence of Staphylococcus aureus independent of its PPIase 
activity. Infect Immun https://doi.org/10.1128/IAI.00379-18. 
 
67. Salisbury V, Hedges RW, Datta N. 1972. Two modes of “curing” transmissible bacterial 
plasmids. J Gen Microbiol 70:443– 452. https://doi.org/10.1099/00221287-70-3-443. 
 
68. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in 
polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. 
https://doi.org/10.1371/journal.pone.0010146. 
 
69. Forsyth RA, Haselbeck RJ, Ohlsen KL, Yamamoto RT, Xu H, Trawick JD, Wall D, Wang L, 
Brown-Driver V, Froelich JM, C KG, King P, McCarthy M, Malone C, Misiner B, Robbins D, 
Tan Z, Zhu Zy ZY, Carr G, Mosca DA, Zamudio C, Foulkes JG, Zyskind JW. 2002. A genome-
wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol 
43:1387–1400. https://doi.org/10.1046/j.1365-2958.2002.02832.x.  
